DarioHealth Corp. (DRIO)
NASDAQ: DRIO · IEX Real-Time Price · USD
1.200
+0.030 (2.56%)
At close: Jul 19, 2024, 4:00 PM
1.120
-0.080 (-6.67%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

DarioHealth Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2012
Cash & Equivalents
34.3736.849.3635.8128.5920.4
Upgrade
Short-Term Investments
0.970.290.170.190.190.19
Upgrade
Cash & Cash Equivalents
35.3437.0949.523628.7820.59
Upgrade
Cash Growth
-18.42%-25.11%37.56%25.10%39.79%83.48%
Upgrade
Receivables
12.265.188.053.383.060.94
Upgrade
Inventory
4.925.067.966.232.291.41
Upgrade
Total Current Assets
52.5147.3365.5245.6134.1322.94
Upgrade
Property, Plant & Equipment
3.241.871.990.991.071.41
Upgrade
Long-Term Investments
0.010.010.010.020.020.02
Upgrade
Goodwill and Intangibles
81.0747.0451.5654.100
Upgrade
Other Long-Term Assets
0.140.140.110.060.190.2
Upgrade
Total Long-Term Assets
84.4649.0653.6755.171.281.63
Upgrade
Total Assets
136.9696.39119.19100.7735.4124.57
Upgrade
Accounts Payable
11.147.438.9112.925.53.68
Upgrade
Deferred Revenue
1.7911.321.21.221.22
Upgrade
Current Debt
4.874.079.120.270.310.32
Upgrade
Total Current Liabilities
17.812.4919.3514.387.035.22
Upgrade
Long-Term Debt
25.5625.4818.930.020.220.46
Upgrade
Other Long-Term Liabilities
15.570.280.910.8300
Upgrade
Total Long-Term Liabilities
41.1325.7519.840.850.220.46
Upgrade
Total Liabilities
58.9338.2539.1915.227.265.68
Upgrade
Total Debt
30.4429.5428.050.290.530.77
Upgrade
Debt Growth
15.42%5.32%9672.82%-46.05%-31.09%-
Upgrade
Retained Earnings
-358.57-349.36-285.85-222.01-143.25-110.15
Upgrade
Shareholders' Equity
78.0358.148085.5528.1518.89
Upgrade
Net Cash / Debt
4.97.5521.4735.7128.2519.81
Upgrade
Net Cash / Debt Growth
-71.07%-64.85%-39.87%26.44%42.55%76.60%
Upgrade
Net Cash Per Share
0.140.270.912.154.748.74
Upgrade
Working Capital
34.7134.8446.1731.2327.0917.72
Upgrade
Book Value Per Share
2.272.053.385.164.728.34
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).